Loading…
The acquisition is expected to expand Aspire's market presence significantly.
Aspire Biopharma Holdings, Inc. announced Aspire Biopharma Holdings, Inc. announced the signing of a definitive share purchase agreement to acquire Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.
The announcement cited $200M+.
Aspire Biopharma Holdings, Inc. has a free float of 4,360,300 shares and 1,295,234 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.